Navigation Links
Major Milestone Reached in Global Maternal Health
Date:3/26/2009

10,000 Women with Fistula Receive Life-Changing Surgery

WASHINGTON, March 26 /PRNewswire-USNewswire/ -- The U.S. Agency for International Development (USAID) and EngenderHealth announced today that 10,000 women have received surgery for fistula with U.S. support since 2005. Fistula, a devastating vaginal injury affecting millions of women in developing countries, can be surgically repaired, but most of those with the condition lack access to a skilled surgeon or health center, making treatment out of reach.

"Today, the United States has achieved a major milestone in improving global maternal health -- giving 10,000 women hope for a better life. None of this would have been possible without the dedication of the local medical teams, government officials, international partners, and the support of the American people," said Gloria Steele, acting assistant administrator in USAID's Bureau for Global Health. "But our work is just beginning."

Four years ago, USAID launched a global effort to both treat and prevent fistula. To date, through initiatives such as the Fistula Care project, and in collaboration with local governments, regional healthcare organizations and faith based organizations, medical teams in 12 countries and 25 health facilities across Africa and Asia have been trained to provide surgery for fistula -- which can be repaired in up to 90 percent of cases.

Fistula is an injury caused by prolonged, obstructed labor that can occur when the head of the baby cannot pass safely through the mother's birth canal. The baby often dies and the mother is left with an abnormal opening in the birth canal and chronic incontinence. If left untreated, fistula can lead to skin ulcerations and infections, kidney disease, social isolation, and even death.

Fistula is almost entirely preventable. Making voluntary family planning available to all could reduce maternal disability and death by at least 20 percent. Complementing that with skilled attendance at all births and improving access to emergency obstetric care and caesarian section could make fistula as rare as it is in the industrialized world. USAID and its partners include strong prevention efforts in their programs, engaging all levels of society -- raising awareness of fistula and its underlying causes that include early pregnancy, poverty, and a lack of girls' education and women's empowerment.

USAID's Fistula care project is managed by EngenderHealth and its partners IntraHealth, CARE, Meridian Group International, Adventist Development and Relief Agency (ADRA) and Society for Women and AIDS in Africa (SWAA). In addition to increasing the number of trained surgeons and leading prevention efforts, Fistula Care project sites offer counseling and support to help women reintegrate into communities that may have shunned them.

Visit www.fistulacare.org for more information or contact fistulacare@engenderhealth.org

For more information about USAID and its programs, please visit: www.usaid.gov.

The American people, through the U.S. Agency for International Development, have provided economic and humanitarian assistance worldwide for nearly 50 years.

Public Information: 202-712-4810


'/>"/>
SOURCE U.S. Agency for International Development
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents
2. SEIU, CNA/NNOC Announce Major Accord
3. Major Asthma Research Discovery Could Lead to New Drugs
4. Health Insurers to Make Major Investment in Primary Care, Patients and Physicians to Benefit
5. Non-Profit Seeks Partners for Major Cover-Up
6. Work Atmosphere Is Worried, Panicky, Say Majority of U.S. Employees
7. Injected Medication Errors a Major Problem
8. Consumers Win Major Victory Over Seafood Scaremongers
9. Leading German Healthcare Group Selects Equipment and Software from Varian Medical Systems for Major Replacement Project
10. New Data Reveals That Gaps in Coverage for Those With Private Insurance Are Major Barriers to Colorectal Cancer Screening
11. Innovative Plans by Major Arizona-Based Developer Sparks Landmark Energy Conservation Legislation in Multiple States to Urge Federal Action at Wall Street Journal Conference This Week with Gore, Google CEO & T. Boone Pickens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Overland Park, KS (PRWEB) , ... June 27, 2016 , ... ... leader in retailers of Eyeglasses . , Millions of individuals in the United ... life, eyeglasses have become a way to both correct vision and make a fashion ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology: